Concepedia

Author

Tapan Saikia

Tata Memorial Hospital

Also Known As

Subhash Varma, T Saikia, Tapan J. Saikia, Tapan Jyoti Saikia, Tapan Saikia, Vijay Anand Reddy

62

Publications

804

Citations

14

H-Index

18

Concepts

All Affiliations

Tata Memorial HospitalPrince Aly Khan HospitalAdvanced Centre for Treatment, Research and Education in CancerImperial College LondonBaylor University Medical Center
TS

About

Tapan Saikia is an author at Tata Memorial Hospital specializing in medicine, oncology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

114

2

Pathology

3

3

64

3

Health Sciences

1

1

26

4

Cell Biology

1

1

36

5

Immunology

1

1

36

Tapan Saikia

×

10

Publications

287

Citations

10

H-Index

YearCitations

Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial

Lia Gore, Pamela Kearns, Maria Lucia de Martino,

Journal of Clinical Oncology

2018

97

Characterisation of blast cells during blastic phase of chronic myeloid leukaemia by immunophenotyping—Experience in 60 patients

Tapan Saikia, Suresh H. Advani, Amar Dasgupta,

Leukemia Research

1988

36

Phase 1 Trial of Vodobatinib, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI): Activity in CML Chronic Phase Patients Failing TKI Therapies Including Ponatinib

Jörge E. Cortes, Tapan Saikia, Dong‐Wook Kim,

Blood

2020

34

Pattern of subtypes of acute lymphoblastic leukemia in India

D Kamat, R. Gopal, Suresh H. Advani,

Leukemia Research

1985

28

Karyotypic findings as an independent prognostic marker in chronic myeloid leukaemia blast crisis

Gouri J. Nanjangud, Pratibha R. Kadam, Tapan Saikia,

Leukemia Research

1994

26

Mycobacterial Pulmonary Infection Post Allogeneic Bone Marrow Transplantation

Unmesh Mohite, Mayukh Das, Tapan Saikia,

Leukemia & lymphoma/Leukemia and lymphoma

2001

16

LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy

Navin Khattry, Alok Gupta, Reetu Jain,

International Journal of Hematology

2016

14

Phase 1 Trial of K0706, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI): In Patients with Chronic Myelogenous Leukemia (CML) and Phildelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Failing ≥ 3 Prior TKI Therapies: Initial Safety and Efficacy

Jörge E. Cortes, Dong‐Wook Kim, Franck E. Nicolini,

Blood

2019

14

Efficacy and Safety of Vodobatinib in Patients (pts) with Chronic Phase Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML): A Sub Group Analysis By Lines of Tyrosine Kinase Inhibitor (TKI) Therapy

Jörge E. Cortes, Tapan Saikia, Dong‐Wook Kim,

Blood

2022

12

Multifocal Extranodal Lymphomas: An Expression of Homing Phenomenon

Suresh H. Advani, R. S. Iyer, R. Gopal,

Oncology

1990

10

Page 1